| Variable | Length of Stay | RR | 95% CI | P value | |
|---|---|---|---|---|---|
| < 4 days | ≥4 days | ||||
| Mortality | – | – | – | – | – |
| Yes | 6 (15.8%) | 32 (84.2%) | 1.125 | 0.424-2.985 | 0.813 |
| No | 8 (14.0%) | 49 (86.0%) | – | – | – |
| Appropriate use during initiation | – | – | – | – | – |
| Appropriate | 12 (15.8%) | 64 (84.2%) | 1.500 | 0.366-6.144 | 0.563 |
| Not Appropriate | 2 (10.5%) | 17 (89.5%) | – | – | – |
| Appropriate use during continuation | – | – | – | – | – |
| Appropriate | 13 (19.4%) | 54 (80.6%) | 1.196 | 1.043-1.373 | 0.047 |
| Not Appropriate | 1 (3.6%) | 27 (96.4%) | – | – | – |
| Pattern of bacteria | – | – | – | – | – |
| Positive gram | 5 (15.2%) | 28 (84.8%) | 1.023 | 0.304-3.438 | 0.971 |
| Negative gram | 4 (14.8%) | 23 (85.2%) | – | – | – |
| Compatibility of Continuation antibiotic | – | – | – | – | – |
| Compatibility | 12 (20.3%) | 47 (79.7%) | 3.661 | 0.869-15.428 | 0.049 |
| Not Compatibility | 2 (5.6%) | 34 (94.4%) | – | – | – |